Credit: Original article published here.In this episode of The Fellow on Call: The Heme/Onc Podcast:Radiation oncology resident Dr. Ryan Miller, of Thomas Jefferson University Hospital, joins the group for the second time to discuss the critical role of radiation therapy in breast cancer management. Specifically, the group details the guidance breast cancer patients receive prior to undergoing radiation therapy, the standard radiation dosing administered to patients following breast cancer surgery, the common side effects of radiation therapy, and much more.
Credit: Original article published here.In this episode of The Fellow on Call: The Heme/Onc Podcast: The group kicks off a comprehensive series on breast cancer. In this episode, they are joined by special guest Dr. Yasha Gupta, from Memorial Sloan Kettering, to elucidate the role breast radiologists play in diagnosing and treating this widespread, and often complex malignancy. Here, you will learn the difference between a screening and diagnostic mammogram, the different techniques employed to perform a breast biopsy, and much more!
Credit: Original article published here.In this episode of The Fellow on Call: The Heme/Onc Podcast: The group is excited to partner with a plethora of their podcasting friends as part of #NephMadness 2023. In this episode, Drs. Matthew Abrahamson, Dr. Timothy Yau, and Dr. Scott Stockholm discuss immune checkpoint inhibitor-related acute kidney injuries (AKIs), and hypomagnesia, two central topics in hemataology/oncology. The group details how checkpoint inhibitors work, the types of AKIs typically linked with immune checkpoint inhibitors, how to workup a suspected checkpoint inhibitor, and much more.
Credit: Original article published here.As The Fellow on Call close of their hemophilia series: The team reviews their previous hemophilia podcasts, and when to suspected acquired hemophilia. They also analyze a hemophilia case study, explain what are Bethesda Units and why they are important, and discuss how to treat not only the condition of hemophilia, but the the underlying cause.
Credit: Original article published here.As The Fellow on Call hemophilia series continues on: The group delineates the acute management of hemophilia patients, particularly with factor replacement. They note that often times factor replacement can be done in the privacy of one’s home at 100% factor activity level, however, factor replacement should always be done before imaging. They also advise on when to give more factor replacement therapy, and advise on various agents to use in different bleeding scenarios.
Credit: Original article published here.The Fellow on Call present part two of their hemophilia series:In this episode, the group distinguishes between the two types of hemophilia: genetic and acquired. Acquired, or hereditary hemophilia, comes in two types: Hemophilia A (characterized by a deficiency in factor VIII), and Hemophilia B (a deficiency in factor IX). In terms of treatment, the team stresses that patients should be treated after their first bleed, with a goal to prevent bleeding while preventing any joint damage. The group also discusses a therapy (emicizumab) that can help treat hereditary hemophilia.
Credit: Original article published here.In this episode of The Fellow on Call: The team tackles the nuances of evaluating a patient with a suspected bleeding disorder, particularly hemophilia. They recommend “The Fellow on Call Bleeding Assessment”, which includes a skin examination, a check for joint or muscle hematoma, and a detailed assessment of past surgeries and any family history of hemophilia. The group also walk through the basic hemophilia workup, and the coagulation cascade.
Credit: Original article published here.The Fellow on Call continue their series on emergencies in hematology and oncology:How do you diagnose thrombotic thrombocytopenic purpura (TTP)? The group points out that clinical presentations including: Fever, anemia, acute kidney injury, as well as a diminished mental state, and noted that if you see these manifestations, the patient is in bad shape. They also characterize the mechanism of TTP (the formation of tiny blood clots, resulting in platelet forming), and how to optimally manage and treat the blood disorder.
Credit: Original article published here.In the following episode of The Fellow on Call: The topic is heparin-induced thrombocytopenia, or HIT, and according to group, whenever a patient with heparin exposure has a new thrombotic event, you should consider HIT. They explain why HIT is more common in the cardiac ICU, how to stratify it, and the proper workup for it.
Credit: Original article published here.In this episode of The Fellow on Call: The group continue their analysis on emergencies by exploring their first hematologic emergency: Immune thrombocytopenic purpura (ITP). They explain how to confirm that the diagnosis is in fact ITP, and subsequently, provide a treatment plan.
